Breakdown | TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 47.02M | 46.37M | 46.51M | 36.04M | 42.62M | 59.69M |
Gross Profit | 22.78M | 2.07M | 3.82M | 2.94M | 2.49M | 11.24M |
EBITDA | -783.00K | -4.09M | 3.81M | 4.51M | 7.18M | 12.16M |
Net Income | -3.17M | -9.78M | -2.76M | -1.30M | -1.24M | 3.60M |
Balance Sheet | ||||||
Total Assets | 78.08M | 83.86M | 93.39M | 85.07M | 87.03M | 102.32M |
Cash, Cash Equivalents and Short-Term Investments | 2.99M | 5.83M | 8.05M | 15.96M | 12.37M | 16.90M |
Total Debt | 44.13M | 46.17M | 41.70M | 29.83M | 36.73M | 43.20M |
Total Liabilities | 61.44M | 66.20M | 65.98M | 57.07M | 57.31M | 68.98M |
Stockholders Equity | 16.63M | 17.66M | 26.84M | 27.59M | 29.13M | 32.75M |
Cash Flow | ||||||
Free Cash Flow | 448.00K | 164.00K | -25.00K | 8.76M | 3.44M | 12.17M |
Operating Cash Flow | 658.00K | 441.00K | 420.00K | 9.32M | 3.79M | 12.67M |
Investing Cash Flow | -313.00K | -263.00K | -445.00K | -920.00K | -433.00K | -497.00K |
Financing Cash Flow | -582.00K | -1.16M | -5.38M | -4.82M | -7.89M | -10.27M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | AU$31.87M | 15.86 | 8.55% | 0.89% | 11.73% | 66.51% | |
65 Neutral | $27.25B | 15.35 | -4.01% | 3.14% | 1.00% | 1.98% | |
64 Neutral | AU$52.69M | 22.01 | 22.69% | ― | 98.84% | ― | |
58 Neutral | AU$34.43M | ― | -85.37% | ― | -15.88% | -1426.12% | |
52 Neutral | AU$176.02M | ― | -28.12% | ― | -0.33% | -671.76% | |
45 Neutral | AU$25.08M | ― | -98.41% | ― | -26.46% | 56.78% | |
45 Neutral | AU$12.73M | ― | -17.65% | ― | -0.14% | 67.13% |
Academies Australasia Group Limited announced a change in the director’s interest, specifically concerning Mr. Christopher Campbell. The notice details the acquisition of 30,000 ordinary shares by Mr. Campbell, increasing his direct shareholding to 2,080,000 while his indirect holdings remain unchanged. This update reflects ongoing adjustments in the company’s governance and shareholding structure, potentially impacting stakeholder perceptions and the company’s market positioning.
Academies Australasia Group Limited announced a change in the director’s interest, specifically for Dr. John Lewis Schlederer, who acquired 300,100 ordinary shares indirectly through entities J&B Schlederer Pty Ltd and Schlederer Nominees Pty Ltd. This acquisition, valued at $39,341.41, reflects an increase in the director’s stake and could signify confidence in the company’s future prospects, potentially impacting stakeholder perceptions positively.
Academies Australasia Group Limited announced a change in the director’s interest notice involving Dr. John Lewis Schlederer. The notice details the acquisition of 381,391 ordinary shares by the director through indirect interests, with no shares disposed of. This update reflects a continued investment in the company by its leadership, which may signal confidence in the company’s future prospects and stability, potentially impacting stakeholder perceptions and market positioning.
Academies Australasia Group Limited announced a change in the director’s interest notice for Mr. Christopher Campbell and Dr. John Lewis Schlederer. This change involves the acquisition of 50,000 ordinary shares by Mr. Campbell, increasing his direct holdings to 2,050,000 shares, while his indirect holdings remain unchanged at 19,350,000 shares. This update reflects ongoing adjustments in the company’s governance and ownership structure, potentially impacting shareholder dynamics and director influence.
Academies Australasia Group Limited announced a change in the director’s interest notice concerning Mr. Christopher Campbell. The change involves the acquisition of 87,389 ordinary shares, increasing his direct holding to 2,000,000 shares. This update reflects the company’s ongoing commitment to transparency and regulatory compliance, potentially impacting stakeholder perceptions and market positioning.
Academies Australasia Group Limited announced a change in the director’s interest involving Mr. Christopher Campbell. The change involved the acquisition of 18,606 ordinary shares, increasing his direct holdings to 1,912,611 shares. This adjustment in shareholding reflects ongoing management and investment activities within the company, potentially impacting stakeholder perceptions and the company’s market positioning.
Academies Australasia Group Limited announced a change in the director’s interest, specifically regarding Dr. John Lewis Schlederer. The change involves the acquisition of 10,000 ordinary shares, increasing his indirect holdings. This development may influence the company’s governance and stakeholder perceptions, reflecting confidence in the company’s future prospects.
Academies Australasia Group Limited announced a change in the director’s interest notice for Dr. John Lewis Schlederer. The change involved the acquisition of 15,244 ordinary shares valued at $1,600.62, reflecting an indirect interest through entities associated with Dr. Schlederer. This update is part of the company’s compliance with ASX listing rules, ensuring transparency in director’s securities dealings.
Academies Australasia Group Limited announced a change in the director’s interest, specifically regarding Mr. Christopher Campbell’s holdings. The update reflects a minor increase in direct shareholding, with no change in indirect holdings. This announcement is part of the company’s compliance with ASX listing rules, ensuring transparency in director dealings, which is crucial for maintaining investor confidence.
Academies Australasia Group Limited announced a change in the director’s interest notice concerning Mr. Christopher Campbell. The change involves the acquisition of 43,999 ordinary shares, bringing his direct holdings to 1,893,999 shares, while his indirect holdings remain unchanged at 19,350,000 shares. This update reflects a modest increase in Mr. Campbell’s stake in the company, potentially signaling confidence in the company’s future prospects.